Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy.

Merhej G, Ramamoorthy G, Chapagai D, Farahani ME, Kong Y, Rao CN, Stafford J, Mack ZT, Socia C, Kumari S, Hogan K, Jani N, Pena MM, Nurmemmedov E, Babic I, Chen M, Liu X, Wyatt MD, McInnes C

Open source

DOI: 10.64898/2026.07.02.736204
Published: 2026 Jul 24
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.07.02.736204,
  title = {Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy.},
  author = {Merhej G and Ramamoorthy G and Chapagai D and Farahani ME and Kong Y and Rao CN and Stafford J and Mack ZT and Socia C and Kumari S and Hogan K and Jani N and Pena MM and Nurmemmedov E and Babic I and Chen M and Liu X and Wyatt MD and McInnes C},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.07.02.736204},
  url = {https://doi.org/10.64898/2026.07.02.736204}
}

RIS

TY  - JOUR
TI  - Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy.
AU  - Merhej G
AU  - Ramamoorthy G
AU  - Chapagai D
AU  - Farahani ME
AU  - Kong Y
AU  - Rao CN
AU  - Stafford J
AU  - Mack ZT
AU  - Socia C
AU  - Kumari S
AU  - Hogan K
AU  - Jani N
AU  - Pena MM
AU  - Nurmemmedov E
AU  - Babic I
AU  - Chen M
AU  - Liu X
AU  - Wyatt MD
AU  - McInnes C
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.07.02.736204
UR  - https://doi.org/10.64898/2026.07.02.736204
ER  -

APA

G, M., G, R., D, C., ME, F., Y, K., CN, R., J, S., ZT, M., C, S., S, K., K, H., N, J., MM, P., E, N., I, B., M, C., X, L., MD, W., & C, M. (2026). Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.07.02.736204

Source records

pubmed · retrieved 2026-11-10T11:36:01.196Z